Leendert Looijenga#
| Membership Number: | 7565 |
| Membership type: | ORDINARY |
| Section: | BASIC AND CLINICAL TRANSLATIONAL SCIENCES |
| Affiliated section(s): | CELL & DEVELOPMENTAL BIOLOGY |
| Elected: | 2026 |
| Main Country of Residence: | THE NETHERLANDS |
| Homepage(s): | https://pure.prinsesmaximacentrum.nl/en/persons/l-looijenga/ |
| ORCID: | 0000-0002-8146-1911 |
| Publication Link: | https://pubmed.ncbi.nlm.nih.gov/?term=looijenga |
Present and Previous Positions
- 2023 Professor of Translational germ cell oncology and fertility, UMCU/UU. Start Juli 15 (5 years).
- 2018 October 1st, 50% PI position Prinses Maxima Center Utrecht (https://www.prinsesmaximacentrum.nl/) and 50% Erasmus University Medical Center; from January 1st 2019: 20 versus 80%; October 2019: 100%
- 2005 Professor of Translational Patho-Oncology, Erasmus University Medical Center (2017 endowed)
- 1999 Assistant Professor Pathology, Academic Hospital Rotterdam/Daniel
- 1994 PhD thesis: “Pathobiology of germ cell tumors of the adult testis; views and news”; Staff member of the Dr. Daniel den Hoed Cancer Center
- 1990-1994: Junior scientist at the Dr. Daniel den Hoed Cancer, started the Laboratory for Experimental Patho-Oncology (LEPO)
Fields of Scholarship
- Sex determination (gonadal development)
- Development and application of diagnostic, prognostic and predictive biomarkers
- Integrated omics
- Normal and malignant germ cells
- Regulation of pluripotency
- Treatment (i.p. platin-based) sensitivity and resistance
- Germ cell transformation including in vitro and in vivo model systems
- Germ cell maturation
- (In)Fertility and preservation
Honours and Awards
- 2011 Emil Steinberger Award (ASA meeting 2-5 April, 2011)
